BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 9551891)

  • 1. Ovalbumin-specific, MHC class I-restricted, alpha beta-positive, Tc1 and Tc0 CD8+ T cell clones mediate the in vivo inhibition of rat IgE.
    MacAry PA; Holmes BJ; Kemeny DM
    J Immunol; 1998 Jan; 160(2):580-7. PubMed ID: 9551891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of rat MHC class-I-restricted ovalbumin-specific IgE inhibitory CD8+ T cell clones.
    MacAry PA; Holmes BJ; Kemeny DM
    Int Arch Allergy Immunol; 1997; 113(1-3):279-80. PubMed ID: 9130548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific CD8+ T cells inhibit IgE responses and interleukin-4 production by CD4+ T cells.
    Holmes BJ; MacAry PA; Noble A; Kemeny DM
    Eur J Immunol; 1997 Oct; 27(10):2657-65. PubMed ID: 9368623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
    Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
    J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.
    Diaz-Sanchez D; Noble A; Staynov DZ; Lee TH; Kemeny DM
    Immunology; 1993 Apr; 78(4):513-9. PubMed ID: 8495968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranes of activated CD4+ T cells expressing T cell receptor (TcR) alpha beta or TcR gamma delta induce IgE synthesis by human B cells in the presence of interleukin-4.
    Gascan H; Aversa GG; Gauchat JF; Van Vlasselaer P; Roncarolo MG; Yssel H; Kehry M; Spits H; De Vries JE
    Eur J Immunol; 1992 May; 22(5):1133-41. PubMed ID: 1349531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
    J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
    Walker PR; Fellowes R; Hecht EM; Lehner T
    J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
    Correale J; Rojany M; Weiner LP
    J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ricin enhances IgE responses by inhibiting a subpopulation of early-activated IgE regulatory CD8+ T cells.
    Diaz-Sanchez D; Lee TH; Kemeny DM
    Immunology; 1993 Feb; 78(2):226-36. PubMed ID: 8097181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
    McKisic MD; Sant AJ; Fitch FW
    J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IgE production and airway reactivity by CD4⁻CD8⁻ regulatory T cells.
    Raker V; Stein J; Montermann E; Maxeiner J; Taube C; Reske-Kunz AB; Sudowe S
    Immunobiology; 2015 Apr; 220(4):490-9. PubMed ID: 25468560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB; Cestari S
    Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-independent regulation of IgE antibody production induced by surface-linked liposomal antigen.
    Taneichi M; Naito S; Kato H; Tanaka Y; Mori M; Nakano Y; Yamamura H; Ishida H; Komuro K; Uchida T
    J Immunol; 2002 Oct; 169(8):4246-52. PubMed ID: 12370355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.